Stocks TelegraphStocks Telegraph
Stock Ideas

CNTX Stock Performance and Key Statistics

NASDAQ : CNTX

Context Therapeutics

$2.48
0.09+3.77%
At Close 4:00 PM
69.46
BESG ScoreESG Rating

stock performance chart

CNTX Fundamental Analysis

Based on recent data, Context Therapeutics Inc. (CNTX) shows an Average True Range (ATR) of 0.21 and an Enterprise Value of 6.31M. Its average trading volume over the past 3 months is 822.46K, indicating liquidity. These fundamental metrics provide insight into CNTX's underlying financial health and market activity.

ATR0.21
Enterprise Value6.31M
Avg Vol (3 Months)822.46K
Avg Vol (10 Days)434.39K

CNTX Technical Analysis Indicators

Context Therapeutics Inc. (CNTX) technical indicators as of May 13, 2026: the SMA 20 is -3.27%, SMA 50 at 23.82%, and SMA 200 at 101.29%. The RSI 14 value is 54.24, suggesting its current momentum. These technical analysis signals help assess CNTX's price trends and potential future movements.

SMA 20-3.27%
SMA 5023.82%
SMA 200101.29%
RSI 1454.24

CNTX Stock Performance Overview

Context Therapeutics Inc. (CNTX) stock performance overview as of May 13, 2026: The 52-week high is $3.62 (currently -20% below), and the 52-week low is $0.49 (currently 365.31% above). Over the past year, CNTX's performance is 57.4%, compared to the S&P 500's 13.01% change.

52-Week High3.62
52-Week High Chg-20.00%
52-Week Low0.49
52-Week Low Chg+365.31%
S&P 500 52-Week Chg13.01%

Context Therapeutics Inc. (CNTX) Historical Stock Performance

According to market data, Context Therapeutics Inc. (CNTX) stock's recent performance metrics show that over the last month, CNTX is 37.5%, with a Year-to-Date (YTD) performance of 4.76%. Over the past year, the stock has seen a 57.4% change. These figures summarize CNTX's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High2.512.833.623.623.623.62
Low2.272.172.020.994950.491.39
Performance+3.36%+37.50%+6.94%+77.28%+57.40%+4.76%

Industry Analysis and Valuation

According to current financial data, CNTX stock's P/E (TTM) ratio is -5.87, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for CNTX, including P/S (N/A), P/B (4.52), and P/FCF (-6.94), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationCNTXSector MedianIndustry AvgS&P 500
P/E (TTM)-5.87-1.22-5.1232.59
P/S (TTM)N/A3.69464.325.98
P/B (TTM)4.52-0.935.794.64
P/FCF (TTM)-6.94-8.54-427.4232.25

Frequently Asked Questions

How is CNTX price-to-earnings ratio currently?
CNTX has a current P/E ratio of -5.87
How are CNTX's price-to-sale and price-to-book ratios?
The CNTX stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 4.52.
Is Context Therapeutics Inc.'s price-to-cashflow ratio high or low?
CNTX's price-to-free-cashflow (P/FCF) ratio is -6.94, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for CNTX?
Based on CNTX's recent bid, its distance from 20 days simple moving average is -3.27%. It is 23.82% apart from 50 days simple moving average, and it is 101.29% apart from 200 days simple moving average.
What is the 52-week price range for CNTX?
The 52-week high for CNTX is $3.62 which is -20% away from the current price level whereas the distance of that from the 52-week low of $0.49 stands at 365.31%.
An overview of CNTX's stock performance: how did it fare?
The performance of CNTX stock was not encouraging with most of its significant price indicators in green. Context Therapeutics Inc.(NASDAQ: CNTX) shares have moved upward +3.77% or $0.09 in the latest trading session and have gained 4.76% year-to-date (YTD). The stock has gained nearly 57.4% over the past year. After moving 6.94% over the trailing 3-month period, the stock is 77.28% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 3.36% a week and 37.5% a month.
What is CNTX's 14-day relative strength index (RSI)?
The current 14-day RSI for CNTX stock is 54.24. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For CNTX, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Context Therapeutics Inc. (CNTX) has a 14-day ATR of 0.21.
What is CNTX's current enterprise value?
After closing at $2.39 with 91.88M of its shares outstanding, the current enterprise value of CNTX is roughly 6.31M.
Over the past year, how has the stock price of CNTX changed?
Context Therapeutics Inc. (NASDAQ: CNTX) is up 57.4% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 13.01%. CNTX stock price is also up 4.76% on its value in year-to-date trading.
What is the average trading volume for CNTX shares?
The number outstanding shares of CNTX is 91.88M, and of these 65.57% shares are freely available for trading. On average, CNTX stock has traded 434.39K shares per day for the past 10 days. A total of 308.68K shares changed hands during the last trading session with the average session volume of 869.62K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph